| 注册
首页|期刊导航|中国药理学通报|干扰素基因刺激因子激动剂的研究进展

干扰素基因刺激因子激动剂的研究进展

王娅 吴硕 李玉环

中国药理学通报2024,Vol.40Issue(4):611-618,8.
中国药理学通报2024,Vol.40Issue(4):611-618,8.DOI:10.12360/CPB202206050

干扰素基因刺激因子激动剂的研究进展

Research progress of STING agonists

王娅 1吴硕 1李玉环1

作者信息

  • 1. 中国医学科学院北京协和医学院医药生物技术研究所,中国医学科学院抗病毒药物研究重点实验室,抗感染药物研究北京市重点实验室,北京 100050
  • 折叠

摘要

Abstract

As an important part of the innate immune system,the cGAS-STING pathway can recognize cytoplasmic DNA from pathogenic microorganisms and host cells,induce the secretion of type Ⅰ interferon and the production of inflammatory cytokines,activate the immune system,resist the invasion of pathogenic mi-croorganisms,and enhance antitumor activity.Here we briefly introduce the mechanism and biological functions of the cGAS-STING pathway,focus on the current research progress of STING agonists,including the pharmacological effects and research sta-ges of STING CDN and Non-CDN agonists,and finally summari-zes and prospects the problems and challenges in the research of STING agonists,in order to provide ideas for the development of related drugs and disease treatment.

关键词

cGAS-STING通路/免疫应答/STING激动剂/Ⅰ型干扰素/抗肿瘤免疫/抗感染免疫

Key words

cGAS-STING pathway/immune response/STING agonists/type Ⅰ interferon/antitumor immunity/anti-infection immunity

分类

医药卫生

引用本文复制引用

王娅,吴硕,李玉环..干扰素基因刺激因子激动剂的研究进展[J].中国药理学通报,2024,40(4):611-618,8.

基金项目

国家自然科学基金青年项目(No 81803592) (No 81803592)

中国医学科学院医学与健康科技创新工程项目(No 2021-1-I2M-030) (No 2021-1-I2M-030)

中国药理学通报

OA北大核心CSTPCD

1001-1978

访问量0
|
下载量0
段落导航相关论文